Zai Lab Ltd. Q1 2025 Financials Filed
Ticker: ZLAB · Form: 10-Q · Filed: May 8, 2025 · CIK: 1704292
| Field | Detail |
|---|---|
| Company | Zai Lab Ltd (ZLAB) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financials, 10-Q, balance-sheet
TL;DR
Zai Lab Q1 2025 financials are in. Stock, capital, earnings detailed.
AI Summary
Zai Lab Ltd. filed its quarterly report for the period ending March 31, 2025. The filing includes financial data for common stock, additional paid-in capital, retained earnings, and accumulated other comprehensive income for both the current quarter and the previous fiscal year-end. Specific dollar amounts and dates for these financial components are detailed within the report.
Why It Matters
This filing provides investors with the latest financial snapshot of Zai Lab Ltd., crucial for understanding the company's financial health and performance in early 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Zai Lab faces inherent risks related to drug development, regulatory approvals, and market competition, which are not fully detailed in this specific filing excerpt.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2024-12-31 — Previous Fiscal Year End (Provides a comparison point to the prior year's financial standing.)
- 2024-01-01 to 2024-03-31 — Comparative Period (Shows financial data for the same period in the previous year for comparison.)
Key Players & Entities
- Zai Lab Ltd (company) — Filer of the 10-Q report
- 2025-03-31 (date) — End of the reporting period
- 2024-12-31 (date) — Previous fiscal year-end
- 2024-01-01 (date) — Start of the comparative period in 2024
- 2024-03-31 (date) — End of the comparative period in 2024
FAQ
What are the specific dollar values for Zai Lab Ltd.'s common stock and additional paid-in capital as of March 31, 2025?
The filing excerpt indicates these values are present for the period ending March 31, 2025, but the specific dollar amounts are not provided in this text.
How do Zai Lab Ltd.'s retained earnings on March 31, 2025, compare to December 31, 2024?
The filing lists retained earnings for both March 31, 2025, and December 31, 2024, allowing for a comparison, though the exact figures are not in this excerpt.
What was the total value of Zai Lab Ltd.'s accumulated other comprehensive income at the end of Q1 2025?
The report covers the period ending March 31, 2025, and includes accumulated other comprehensive income, but the specific value is not detailed in this provided text.
Does the filing provide any information on Zai Lab Ltd.'s revenue for the first quarter of 2025?
This excerpt focuses on balance sheet items like common stock and retained earnings and does not appear to contain specific revenue figures for Q1 2025.
When was the 10-Q filing for Zai Lab Ltd. submitted?
The filing accession number indicates it was filed on May 8, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Zai Lab Ltd (ZLAB).